Justices Want SG's Take On Enablement In Antibody IP Fight

By Britain Eakin ( April 18, 2022, 4:59 PM EDT) -- The U.S. Supreme Court asked the solicitor general Monday to weigh in on Amgen's bid to undo a Federal Circuit decision tossing its jury win against Sanofi and Regeneron Pharmaceuticals Inc. after finding two antibody patents on its cholesterol medication Repatha aren't enabled....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!